Cancer Cells

In a malignant tumor, cancer cells are sparsely distributed throughout the mass of dead cells, with blood circulation, neurological flow, and lymphatic circulation maintained into the tumor through the cancer cells themselves. This circulation is what makes malignant tumors addressable by the body. Because nutrients and signals can still reach the cancer cells through the bloodstream, the body retains the ability to trigger the dissolution process when it has accumulated sufficient resources to handle the toxic byproduct.

Aajonus described the cancer cell as functioning like a hermit or ascetic: isolated, surrounded by death, not requiring communication with neighboring live cells the way normal cells do, yet still connected to the body through the blood, neurological flow, and lymph. This isolation is what allows a cancer cell to survive in an environment of 50 to 500 dead cells on all sides. Normal cells cannot do this; they depend on communication with surrounding live cells for nutrients and signaling. The cancer cell produces prostaglandins and viral-type fluids that allow it to dissolve matter in its immediate environment and absorb nutrients from the resulting breakdown products, somewhat analogously to how a plant dissolves soil matter and draws nutrients from it.

He also described the cancer cell as maintaining communication with the body "on a psychic level, on a radionic level," ensuring that even a region completely surrounded by dead tissue is not entirely cut off from the body's systemic awareness. This maintained connection is part of what allows the body to eventually coordinate the dissolution of the tumor when conditions are right.

When the body accumulates enough resources, including proper fats, functioning lymphatic activity, and improved liver output of bile and cholesterol, it initiates the dissolution process by allowing the cancer cells to die. Each dying cancer cell releases its solvent load, which in his descriptions contained muriatic acid-like substances and viral-type fluids. This dissolution can eliminate 50 to 200 dead cells per cancer cell death, and in a tumor with cancer cells distributed throughout, this cascade can dissolve the entire tumor very rapidly.

Aajonus cited dissolution timelines ranging from two days to five years depending on tumor size, location, number of tumors, and the body's available resources. He mentioned brain tumors dissolving in as little as two to five days. He described cases where malignant tumors disappeared overnight, within 15 days, or within a month. For larger or more advanced situations, dissolution could take three to five years. He contrasted this directly with benign tumors, which he said could take 30 to 40 years to dissolve from the outside in, or might never dissolve without surgical removal.

The waste product left after cancer cell dissolution is highly toxic and acrid. Whatever industrial chemicals originally killed the cells and contributed to the dead cell accumulation are now released in concentrated dissolved form. Aajonus described this dissolved waste as capable of damaging and dissolving healthy surrounding tissue if the body does not have sufficient fat stores to bind with the toxins. He described fat, particularly storage fat, as the critical protective buffer that neutralizes this waste. Without adequate fat, the acrid dissolving substance continues breaking down anything it contacts, including healthy live tissue, which in advanced cases produces visible tissue destruction such as open wounds near tumor sites, or flesh appearing to melt.

He described the consequences of this situation with a specific case of a breast cancer patient whose flesh was dissolving through the skin, and explained that this was the dissolved dead-cell waste exiting through the skin because the body lacked sufficient fats to contain and neutralize it internally. The lymphatic system is responsible for managing dissolved dead-cell waste by placing it under the skin for eventual elimination through perspiration, but when fats are insufficient and the lymphatic system is impaired, the acids damage healthy cells on their way out.

Aajonus consistently described cancer cells as "viral cells," meaning they operate on the same principle as what he called viruses throughout his framework: they are internally produced solvents, not infectious pathogens. The fluid inside a cancer cell is "almost identical to a virus" in its chemical function, acting as a solvent to dissolve hardened, mummified, dead cellular material. This is why he placed cancer cells in the same conceptual category as viruses and described both as the body's internally generated chemical tools for cleanup.

He stated that the body turns to viral-type solvents precisely when bacterial, parasitic, and fungal assistance is not available. Bacteria, parasites, and fungi are the body's preferred cleanup crew for dead cells because their excretions neutralize the toxic byproducts of cellular dissolution, making the waste safer to handle. In an environment heavily contaminated with industrial chemicals such as thallium or benzene, bacteria and parasites cannot survive, and fungi cannot colonize. The body then has no choice but to generate its own solvents, which is what the cancer cell does, but the byproduct of this solvent action is far more acidic and damaging than what bacteria and fungi would produce, because the microbial excretions that normally neutralize the waste are absent.

In "We Want to Live," Aajonus developed the analogy that calling cancer cells responsible for tumors is like calling roosters responsible for sunrise. The cancer cells are caretakers of the catacombs, not the architects of the problem. The problem is the inability to eliminate dead cells, which has its root causes in industrial chemical exposure, lymphatic congestion, liver insufficiency, and fat deficiency. Cancer cells appear in response to that problem, not as its creators.

He extended this analogy to critique chemotherapy directly: killing cancer cells along with billions of healthy cells does not address the dead cell accumulation that created the tumors. The dead cells remain, more dead cells are added by the chemotherapy's cellular destruction, and the underlying inability to dissolve dead cells is made worse, not better. He calculated that for every one cancer cell chemotherapy kills, at least one billion healthy cells are killed, and drew the analogy that if four individuals were declared cancerous to the human race, the medical profession would be willing to kill four billion people to eliminate those four.

When asked about the multiplying factor of cancer cells producing more cancer cells, Aajonus's answer was direct: the body produces more cancer cells in order to dissolve more dead matter. If a tumor contains an enormous accumulation of dead cells, a single cancer cell cannot dissolve enough of it. More cancer cells are generated to match the scale of the dissolution task. Cancer cell multiplication, in his framework, is not a runaway destructive process but a proportional scaling-up of the body's dissolution capacity in response to the volume of dead tissue that needs to be cleared.

Normal cells require adjacency to other live cells to receive nutrients and signals through the lymphatic system and cellular communication networks. A cell surrounded entirely by dead cells would be cut off and unable to function. The cancer cell is specifically mutated to circumvent this dependency: it produces its own dissolving fluids that release nutrients from the surrounding dead matter, sustaining itself on what it dissolves. Aajonus compared this to a plant or tree that dissolves surrounding soil matter and draws nourishment from it. This capacity is what allows one cancer cell to survive in the center of hundreds of dead cells, maintain systemic communication with the brain and nervous system, and continue producing the solvents needed to eventually dissolve the tumor.

Because cancer cells are the body's agents for dissolving dead cell accumulations, and because the lymphatic system is the primary site where dead cells are processed and eliminated, Aajonus pointed out that finding cancer cells in lymph nodes is expected and normal, not an indicator of dangerous spread. He stated that lymph glands will always have cancer cells in them when the body is dealing with dead cell accumulations anywhere in the body. He explicitly said "expect it," and argued that the medical profession's treatment threshold of 50 cancer cells per million total cells as "treatable cancer" is an arbitrary and commercially motivated threshold designed to generate patients for treatment, not a meaningful clinical indicator of danger.

He was particularly critical of lymph node removal and lymphectomy, calling it "insane" except in cases where a lymph node has hardened to the consistency of rock, not merely rubber-like firmness. Removing lymph nodes eliminates part of the body's cancer-dissolving infrastructure, and he described cases where women who had lymph nodes removed from the breast area found their cancer then migrating to the lungs and armpits, the only remaining locations where dead cells could accumulate after the normal lymphatic channels had been destroyed.

Fat was the nutrient Aajonus returned to most consistently in discussions of cancer. Storage fat is the body's binding and neutralizing medium for the highly toxic dissolved waste that cancer cells release when they die. Without adequate body fat, the acrid waste flows freely through the body after dissolution and damages healthy tissue. He recommended that cancer patients get 20 to 25 pounds overweight before allowing the dissolution process to accelerate, so that the body has enough fat to absorb and neutralize the toxins.

He described cancer as "basically a fat deficiency" in one passage from "We Want to Live," specifying that it is a deficiency of utilizable cholesterol that normally binds with, dissolves, carries away, and eliminates dead cells. Properly digested fats from stone-pressed olive oil were described as dissolving dead cells directly, while fats from raw eggs act as sacrificial garbage collectors, binding with dead cells or dissolved waste and carrying the toxins to elimination sites. Without these fats, the lymphatic system cannot perform its normal function of dissolving dead cells on a daily basis.

Aajonus was consistent that cancer patients who are thin or skinny are at severe risk when the tumor begins dissolving, because the released toxins have nothing to bind with. He referenced a case of a 28-year-old woman with breast cancer, kidney tumors, and hip bone cancer who needed to gain weight before the dissolution process could be safely managed. In another case, a breast cancer patient had been "ultra skinny" and he worked to get her to put on 25 pounds, wanting her at 35 pounds above her previous weight, because without that fat reserve the dissolving tumor's acrid waste would burn through surrounding healthy tissue.

Aajonus stated repeatedly that nobody develops cancer without severe accumulation of industrial chemicals in the dead cells. Cancer is not a natural condition for animals or humans living in unpolluted environments. He cited Samuel Epstein, whom he described as an octogenarian MD and one of the world's greatest experts on cancer, who stated that the only cure for cancer is diet, and that all conventional medical treatments for cancer are harmful and promote more cancer. Aajonus quoted Epstein's statistics that one out of two men and one out of three women in the contemporary United States develops cancer, compared to one out of 100,000 people 200 years ago.

He identified specific industrial chemicals as causes of specific cancers: cadmium concentrations causing kidney cancer, mercury causing pancreatic, liver, and brain tumors. He stated that cancer was historically found only among metallurgists and foundry workers, people with heavy direct chemical exposure, because those were the only environments where sufficient cellular destruction and dead cell accumulation occurred to produce cancer. The broader epidemic of cancer is, in his view, directly attributable to fried foods, processed cereals, potato chips, french fries, vaccines, medications, and industrial contamination of the food and environment.

He described chemotherapy as a poison that destroys cells and creates more dead cells that the body cannot dissolve, which generates more tumors rather than eliminating them. He cited his own experience of receiving chemotherapy and radiation that transformed a stomach ulcer into stomach cancer and then into blood and bone cancer (multiple myeloma), describing the chemotherapy as killing one cancer cell for every two billion healthy cells destroyed.

The pharmaceutical and medical industry defines "treatable cancer" as a concentration of approximately 50 cancer cells per million cells. Aajonus described this threshold as arbitrary and commercially driven, pointing out that if cancer cells function as the body's dissolving agents and are always present in lymph nodes, then finding 50 per million in a biopsy sample is not evidence of dangerous pathology but of normal lymphatic activity. He suggested that a genuinely concerning concentration might be 100,000 to 200,000 cancer cells per million before any intervention would be rationally warranted, and that even then the appropriate response would be dietary, not chemical or radiation-based.

He noted that laboratory reports use the word "treatable" without specifying the parts-per-million figure, and that when patients pressed laboratories for the actual number, they might find they had 49 per million (borderline) or 60 per million. The system is constructed, in his view, to generate treatment revenue rather than to reflect genuine biological risk assessment.

Across multiple passages, Aajonus gave a range of dissolution timelines for malignant tumors, always noting the variability:

A malignant tumor can dissolve in as few as two days. Brain tumors can dissolve in two to five days under the right conditions. General malignant tumors may dissolve in two to five days, five to fifteen days, one month, two years, three to five years, or up to ten to fifteen years depending on size, number, patient condition, and nutrient status. He contrasted this consistently with benign tumors, which may take 30 to 40 years to dissolve from the outside inward, or may require surgical removal because the body never generates enough extracellular solvents to complete the dissolution.

Aajonus referenced multiple cases throughout the source passages. One woman came to him at age 36 with breast cancer; he had her gain weight before the dissolution process advanced. Another patient, 28 years old, had breast cancer, kidney tumors attached to the adrenal glands, and cancer of the hip bone that was dissolving bone rather than forming a solid tumor. He referenced a woman from New Zealand who came to him after her first chemotherapy treatment, whom he warned would develop metastatic cancer within five years due to the additional dead cell load from the chemotherapy. He referenced an MD patient whose condition was so severe, with extensive cancer throughout the face and throat, that fully natural dissolution would have dissolved his entire face and throat in the process. He described a woman from Mexico whose cancer markers returned completely to normal within 30 days of beginning the diet.

He stated that through 1992 to 1993 he had reversed 95% of cancer cases he worked with, and that by the time of the later lectures the figure had risen to 97%.

A practical clinical point Aajonus made was that the body stores dead cells in muscle tissue before resorting to tumor formation. Someone with adequate muscle mass has more capacity to distribute dead cells throughout the body without concentrating them into tumors. A person who is skin and bones with no muscle tissue has no storage buffer and will build tumors rapidly because there is nowhere else to put the dead cells. In such cases, Aajonus said the first priority was not to address the cancer directly but to get muscle meat into the body to build muscle tissue, creating the storage capacity that would slow or stop tumor formation while the body gradually improved its ability to dissolve and eliminate dead cells.

When cancer cells begin dying and releasing solvents, and the dissolved dead-cell waste exits through the skin without adequate fat buffering, visible external manifestations appear. Aajonus described white molds, black molds, and gangrene appearing on the skin where cancers reach the surface, and described these as the body's attempt to clean dead cells out of the body through the skin using fungal assistance when internal dissolution has produced more waste than the lymphatic system can handle. Open wounds near tumor sites represent the body throwing dissolved dead-cell waste through the skin because it lacks sufficient fats to protect the surrounding healthy tissue. He described a breast cancer case where layers of dead cells were visible in a glob just beginning to break through the skin surface.

Aajonus's position was unambiguous: a malignant tumor with cancer cells is preferable to a benign tumor without them, because the cancer cells provide the internal mechanism for dissolution. Without cancer cells, the body must dissolve the tumor entirely from the outside inward with no circulation into the mass, no solvent release from within, and no lymphatic or neurological flow inside the tumor. He called benign tumors something he hated, and said he preferred cancer. A benign tumor that is large may literally never dissolve in the patient's lifetime without surgical removal. A malignant tumor of the same size can potentially dissolve within days to years, because the cancer cells provide the solvent apparatus that makes internal dissolution possible.

---